Fkbp10-KO 基因敲除小鼠

下单100%中奖,最高可得千元京东卡
复苏/繁育服务
产品名称

Fkbp10-KO 基因敲除小鼠

产品编号

S-KO-02070

品系全称

C57BL/6JCya-Fkbp10em1/Cya

品系背景

C57BL/6JCya

品系编号

KOCMP-14230-Fkbp10-B6J-VA

品系状态

使用本品系发表的文献需注明: Fkbp10-KO 基因敲除小鼠 mice (Strain S-KO-02070) were purchased from Cyagen.
交付类型
周龄
性别
基因型
数量

基本信息

基因研究概述

质控标准

基因
基因全称
FK506 binding protein 10
基因别称
FKBP-10,FKBP-65,FKBP65,Fkbp-rs1,Fkbp1-rs,Fkbp6,Fkbprp
染色体号
Chr 11 (Mouse)
转录本 ID
NCBI: NM_010221 | Ensembl: ENSMUST00000001595
修饰方式
全身性基因敲除
靶向范围
Exon 2
敲除长度
~1.6 kb
品系说明
该品系是基于策略设计时的数据库信息制作而成,建议您在购买前查询最新的数据库和相关文献,以获取最准确的表型信息。
表型提示
MGI:104769Homozygous null mice do not survive birth, and embryos exhibit delayed growth, tissue fragility, decreased aorta wall thickness, craniofacial and forelimb anomalies, and connective tissue alterations. Mutant MEFs retain procollagen in the cell layer and show dilated endoplasmic reticulum.
FKBP10,全称FK506结合蛋白10,是一种属于FKBP(FK506结合蛋白)家族的蛋白质。FKBP家族成员是一类重要的肽基脯氨酰顺反异构酶(PPIase),它们在蛋白质折叠、细胞信号转导和基因表达调控等方面发挥着重要作用。FKBP10具有PPIase活性,能够催化蛋白质中脯氨酸残基的顺反异构化,从而影响蛋白质的折叠和功能。

FKBP10在多种癌症中表达异常,并参与肿瘤的发生和发展。在肾细胞癌中,FKBP10通过促进糖酵解途径和增强LDHA的磷酸化,促进肿瘤细胞的增殖和转移[1]。在胶质瘤中,FKBP10通过与Hsp47相互作用,激活AKT-CREB-PCNA信号通路,促进肿瘤细胞的增殖[2]。在肺癌中,FKBP10通过其PPIase活性促进肿瘤生长和干细胞特性,并参与蛋白质翻译的调控[3]。在胃癌中,FKBP10通过调节PI3K信号通路,促进肿瘤细胞的增殖、侵袭和迁移[4]。此外,FKBP10还与胃癌的免疫微环境和预后相关,可以作为预测预后的生物标志物[5,6]。在膀胱癌中,FKBP10通过调节核纤层蛋白A的表达,促进肿瘤细胞的侵袭和转移[7]。在骨质疏松症中,FKBP10的缺失会导致骨骼质量缺陷[8]。在肺腺癌脑转移中,FKBP10的表达与患者的生存时间密切相关,可以作为预测预后的生物标志物[9]。

综上所述,FKBP10是一种重要的蛋白质,在多种生物学过程中发挥着重要作用。FKBP10在多种癌症中表达异常,并参与肿瘤的发生和发展。FKBP10的研究有助于深入理解肿瘤的发生和发展机制,为肿瘤的治疗和预防提供新的思路和策略。

参考文献:
1. Liu, Ren, Zou, Zhihao, Chen, Lingwu, Wang, Zongren, Zhong, Weide. 2024. FKBP10 promotes clear cell renal cell carcinoma progression and regulates sensitivity to the HIF2α blockade by facilitating LDHA phosphorylation. In Cell death & disease, 15, 64. doi:10.1038/s41419-024-06450-x. https://pubmed.ncbi.nlm.nih.gov/38233415/
2. Cai, Hong-Qing, Zhang, Min-Jie, Cheng, Zhi-Jian, Wang, Ming-Rong, Wan, Jing-Hai. 2021. FKBP10 promotes proliferation of glioma cells via activating AKT-CREB-PCNA axis. In Journal of biomedical science, 28, 13. doi:10.1186/s12929-020-00705-3. https://pubmed.ncbi.nlm.nih.gov/33557829/
3. Ramadori, Giorgio, Ioris, Rafael M, Villanyi, Zoltan, Collart, Martine A, Coppari, Roberto. . FKBP10 Regulates Protein Translation to Sustain Lung Cancer Growth. In Cell reports, 30, 3851-3863.e6. doi:10.1016/j.celrep.2020.02.082. https://pubmed.ncbi.nlm.nih.gov/32187554/
4. Wang, Ruo-Gu, Zhang, Dan, Zhao, Chun-Hong, Qu, Hui, He, Qing-Si. 2019. FKBP10 functioned as a cancer-promoting factor mediates cell proliferation, invasion, and migration via regulating PI3K signaling pathway in stomach adenocarcinoma. In The Kaohsiung journal of medical sciences, 36, 311-317. doi:10.1002/kjm2.12174. https://pubmed.ncbi.nlm.nih.gov/31868996/
5. Chang, Jingjia, Wu, Hao, Wu, Jin, Yu, Pengfei, Zhu, Jianjun. 2023. Constructing a novel mitochondrial-related gene signature for evaluating the tumor immune microenvironment and predicting survival in stomach adenocarcinoma. In Journal of translational medicine, 21, 191. doi:10.1186/s12967-023-04033-6. https://pubmed.ncbi.nlm.nih.gov/36915111/
6. Zhao, Xupeng, Wang, Jichen, Tian, Shuo, Li, Xiubin, Li, Hongzhao. 2025. FKBP10 Promotes the Muscle Invasion of Bladder Cancer via Lamin A Dysregulation. In International journal of biological sciences, 21, 758-771. doi:10.7150/ijbs.105265. https://pubmed.ncbi.nlm.nih.gov/39781460/
7. Liang, Liang, Zhao, Kun, Zhu, Jin-Hui, Qin, Xin-Gan, Chen, Jun-Qiang. 2019. Comprehensive evaluation of FKBP10 expression and its prognostic potential in gastric cancer. In Oncology reports, 42, 615-628. doi:10.3892/or.2019.7195. https://pubmed.ncbi.nlm.nih.gov/31233188/
8. Gong, Li-Bao, Zhang, Chuang, Yu, Ruo-Xi, Liu, Yun-Peng, Qu, Xiu-Juan. 2020. FKBP10 Acts as a New Biomarker for Prognosis and Lymph Node Metastasis of Gastric Cancer by Bioinformatics Analysis and in Vitro Experiments. In OncoTargets and therapy, 13, 7399-7409. doi:10.2147/OTT.S253154. https://pubmed.ncbi.nlm.nih.gov/32801763/
9. Lietman, Caressa D, Lim, Joohyun, Grafe, Ingo, Krakow, Deborah, Lee, Brendan H. 2017. Fkbp10 Deletion in Osteoblasts Leads to Qualitative Defects in Bone. In Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 32, 1354-1367. doi:10.1002/jbmr.3108. https://pubmed.ncbi.nlm.nih.gov/28206698/